SCHEMBL6487666

SCHEMBL6487666

CS(=O)(=O)N1CCN(CCCCCCN2C(=O)C=CC2=O)CC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 5/20 0.53
▸ FAAH O00519 3/20 0.53
▸ HSP90AA1 P07900 1/20 0.53
▸ TLR9 Q9NR96 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ TP53 P04637 1/20 0.53
▸ MAPT P10636 1/20 0.53
▸ PKM P14618 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ XBP1 P17861 1/20 0.53
▸ MAPK1 P28482 1/20 0.53
▸ HTT P42858 1/20 0.53
▸ RECQL P46063 1/20 0.53
▸ RAB9A P51151 1/20 0.53
▸ SMN1; SMN2 Q16637 1/20 0.53
▸ NPSR1 Q6W5P4 1/20 0.53
▸ GPR35 Q9HC97 1/20 0.53
▸ GPR55 Q9Y2T6 1/20 0.53
▸ PTGS2 P35354 9/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4300433 0.79 MGLL (0.65) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL38665905 0.76 GNAI3 (0.53) PTGS2KDM4EHRH2HRH1
SCHEMBL6484741 0.75 KDM4E (0.41) ALDH1A1NPSR1PTGS2KDM4EKDM1A
SCHEMBL6485200 0.75 KDM4E (0.41) ALDH1A1NPSR1PTGS2KDM4EKDM1A
SCHEMBL20376410 0.74 HRH2 (0.52) PTGS2KDM4EKDM1AHRH2HRH1
SCHEMBL4508386 0.74 KDM1A (0.42) ALDH1A1SMN1; SMN2NPSR1PTGS2KDM4E
SCHEMBL258626 0.73 MGLL (1.00) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL549065 0.73 MGLL (1.00) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL20351983 0.73 MGLL (1.00) MGLLFAAHHSP90AA1TLR9ALDH1A1
SCHEMBL818349 0.73 MGLL (1.00) MGLLFAAHHSP90AA1TLR9ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6861432-B2 Piperazine derivatives that destabilize androgen receptors SCHERING AKTIENGESELLSCHAFT (DE) 2005-03-01 — — US disclosed
Send feedback